MGNX - MacroGenics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5643.44M
Enterprise Value 3407.54M
Trailing P/E N/A
Forward P/E 1-3.55
PEG Ratio (5 yr expected) 10.01
Price/Sales (ttm)11.32
Price/Book (mrq)2.19
Enterprise Value/Revenue 37.17
Enterprise Value/EBITDA 6-2.45

Trading Information

Stock Price History

Beta (3Y Monthly) 1.24
52-Week Change 3-42.66%
S&P500 52-Week Change 32.59%
52 Week High 332.32
52 Week Low 39.87
50-Day Moving Average 314.12
200-Day Moving Average 316.43

Share Statistics

Avg Vol (3 month) 3475.12k
Avg Vol (10 day) 3538.8k
Shares Outstanding 548.89M
Float 44.39M
% Held by Insiders 17.12%
% Held by Institutions 178.27%
Shares Short (Aug 15, 2019) 44.42M
Short Ratio (Aug 15, 2019) 410.15
Short % of Float (Aug 15, 2019) 49.36%
Short % of Shares Outstanding (Aug 15, 2019) 49.04%
Shares Short (prior month Jul 15, 2019) 44.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -273.47%
Operating Margin (ttm)-311.83%

Management Effectiveness

Return on Assets (ttm)-28.76%
Return on Equity (ttm)-51.27%

Income Statement

Revenue (ttm)56.85M
Revenue Per Share (ttm)1.27
Quarterly Revenue Growth (yoy)-43.80%
Gross Profit (ttm)-130.71M
EBITDA -166.05M
Net Income Avi to Common (ttm)-155.46M
Diluted EPS (ttm)-3.47
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)272.14M
Total Cash Per Share (mrq)5.57
Total Debt (mrq)27.92M
Total Debt/Equity (mrq)9.48
Current Ratio (mrq)5.81
Book Value Per Share (mrq)6.02

Cash Flow Statement

Operating Cash Flow (ttm)-143.05M
Levered Free Cash Flow (ttm)-85.59M